CN101677572B - 制备钌络合物的方法 - Google Patents
制备钌络合物的方法 Download PDFInfo
- Publication number
- CN101677572B CN101677572B CN2008800190776A CN200880019077A CN101677572B CN 101677572 B CN101677572 B CN 101677572B CN 2008800190776 A CN2008800190776 A CN 2008800190776A CN 200880019077 A CN200880019077 A CN 200880019077A CN 101677572 B CN101677572 B CN 101677572B
- Authority
- CN
- China
- Prior art keywords
- indazole
- ruthenium
- tetrachloro
- iii
- hydrochlorate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000012327 Ruthenium complex Substances 0.000 title description 9
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims abstract description 86
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 21
- -1 alkali metal salt Chemical class 0.000 claims abstract description 21
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 64
- 229910052707 ruthenium Inorganic materials 0.000 claims description 64
- 239000003960 organic solvent Substances 0.000 claims description 37
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000000605 extraction Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 10
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 10
- 239000010452 phosphate Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical group ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003208 petroleum Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical class CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 4
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- 150000004675 formic acid derivatives Chemical class 0.000 claims description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 4
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical group [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 14
- 239000000047 product Substances 0.000 description 5
- 208000035126 Facies Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000003495 polar organic solvent Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000003513 alkali Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003799 water insoluble solvent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94328307P | 2007-06-11 | 2007-06-11 | |
US60/943,283 | 2007-06-11 | ||
PCT/US2008/066456 WO2008154553A1 (en) | 2007-06-11 | 2008-06-10 | Method of manufacturing a ruthenium complex |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101677572A CN101677572A (zh) | 2010-03-24 |
CN101677572B true CN101677572B (zh) | 2013-11-20 |
Family
ID=40130192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008800190776A Expired - Fee Related CN101677572B (zh) | 2007-06-11 | 2008-06-10 | 制备钌络合物的方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8362266B2 (zh) |
EP (1) | EP2152084B1 (zh) |
JP (1) | JP5296063B2 (zh) |
CN (1) | CN101677572B (zh) |
CA (1) | CA2686834C (zh) |
ES (1) | ES2441262T3 (zh) |
PT (1) | PT2152084E (zh) |
WO (1) | WO2008154553A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2517367T3 (es) | 2009-12-11 | 2014-11-03 | Niiki Pharma Inc. | Procedimiento de tratamiento de cáncer pancreático |
ES2539160T3 (es) * | 2010-04-19 | 2015-06-26 | Niiki Pharma Inc. | Procedimiento de tratamiento de cáncer gástrico |
EP2560639A4 (en) * | 2010-04-23 | 2013-10-30 | Niiki Pharma Inc | METHOD FOR THE TREATMENT OF PROSTATE CANCER |
WO2011139867A2 (en) * | 2010-04-29 | 2011-11-10 | Niiki Pharma Inc. | Method of treating brain cancer |
KR101639470B1 (ko) | 2010-10-25 | 2016-07-13 | 니키 파머 인코포레이티드 | 신경내분비 종양의 치료방법 |
KR20130122763A (ko) * | 2010-12-02 | 2013-11-08 | 우베 고산 가부시키가이샤 | 2 핵 금속 착물, 및 그를 사용한 유기 일렉트로루미네선스 소자 |
JP2014516966A (ja) * | 2011-05-17 | 2014-07-17 | ニキ ファーマ アクィジション コーポレイション 2 | 癌を処置するための医薬および方法 |
WO2013070988A2 (en) * | 2011-11-09 | 2013-05-16 | Niiki Pharma Inc. | Method of treating osteosarcoma |
CN103601759B (zh) * | 2013-10-18 | 2015-08-19 | 武汉利宝瑞医药科技有限公司 | 一种用于治疗肿瘤的钌(iii)络合物的制备方法 |
CN109195600A (zh) | 2016-03-01 | 2019-01-11 | 茵肽锌科技公司 | 反式-[四氯双(1h-吲唑)钌(iii)酸盐]用于治疗癌症的用途 |
JP7183253B2 (ja) | 2017-05-05 | 2022-12-05 | インテザイン テクノロジーズ, インコーポレイテッド | トランス-[テトラクロロビス(1h-インダゾール)ルテニウム酸(iii)]及びその組成物の製造 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0694471B2 (ja) | 1984-07-24 | 1994-11-24 | アスタ・メディカ・アクチエンゲゼルシヤフト | 薬理学的に認容性の錯化合物およびその製造法 |
IT1230145B (it) * | 1989-05-05 | 1991-10-14 | Boehringer Biochemia Srl | Complessi di rutenio (iii) come agenti antineoplastici. |
DE19612291A1 (de) * | 1996-03-28 | 1997-10-02 | Bernhard K Prof Dr Dr Keppler | Arzneimittelzubereitungen enthaltend tumorhemmend wirkende Ruthenium(III)-Komplexe |
DE10103565B4 (de) * | 2001-01-26 | 2007-06-14 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus |
-
2008
- 2008-06-10 PT PT87706164T patent/PT2152084E/pt unknown
- 2008-06-10 CA CA2686834A patent/CA2686834C/en not_active Expired - Fee Related
- 2008-06-10 ES ES08770616.4T patent/ES2441262T3/es active Active
- 2008-06-10 WO PCT/US2008/066456 patent/WO2008154553A1/en active Application Filing
- 2008-06-10 JP JP2010512304A patent/JP5296063B2/ja not_active Expired - Fee Related
- 2008-06-10 CN CN2008800190776A patent/CN101677572B/zh not_active Expired - Fee Related
- 2008-06-10 EP EP08770616.4A patent/EP2152084B1/en not_active Not-in-force
-
2009
- 2009-12-11 US US12/636,025 patent/US8362266B2/en active Active
Non-Patent Citations (1)
Title |
---|
Wolfgang Peti et al.,.Synthesis of Tumor-Inhibiting Complex Salts Containing the Anion trans-Tetrachlorobis(indazole)ruthenate(III) and Crystal Structure of the Tetraphenylphosphonium Salt.《European Journal of Inorganic Chemistry》.1999,第1999卷(第9期),第1551页右栏第2段至第1552页左栏第2段. * |
Also Published As
Publication number | Publication date |
---|---|
EP2152084A1 (en) | 2010-02-17 |
EP2152084B1 (en) | 2013-12-18 |
US8362266B2 (en) | 2013-01-29 |
EP2152084A4 (en) | 2012-05-02 |
JP2010529202A (ja) | 2010-08-26 |
PT2152084E (pt) | 2014-01-23 |
US20100094019A1 (en) | 2010-04-15 |
WO2008154553A1 (en) | 2008-12-18 |
CA2686834C (en) | 2014-05-27 |
JP5296063B2 (ja) | 2013-09-25 |
ES2441262T3 (es) | 2014-02-03 |
CA2686834A1 (en) | 2008-12-18 |
CN101677572A (zh) | 2010-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101677572B (zh) | 制备钌络合物的方法 | |
CN102812030B (zh) | 纯化葫芦脲的方法 | |
Mattsson et al. | Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage | |
CN108250250B (zh) | 含1,1,1-三苯基-n-(1-(吡啶-2-)亚甲基)甲胺的配合物及制备方法、应用 | |
AU3951000A (en) | Process for preparing amine platinum complexes | |
Samanta et al. | Guest encapsulation and coronene–C 60 exchange in supramolecular zinc porphyrin tweezers, grids and prisms | |
Hu et al. | Self-assembly of reverse micelle nanoreactors by zwitterionic polyoxometalate-based surfactants for high selective production of β‑hydroxyl peroxides | |
CN110272457B (zh) | 一种具有光活化性能的钌配合物及其制备方法和应用 | |
Zhao et al. | Syntheses, structural characterizations and properties of 12-MC-4 organotin (IV) metallacrowns:[12-MCRSn (IV) N (shi)-4] and [12-MCRSn (IV) N (Clshi)-4](R= Et, Bu, Ph; H3shi= salicylhydroxamic acid; H3Clshi= 5-chlorosalicylhydroxamic acid) | |
CN111808111A (zh) | 铱配合物及其制备方法、光动力学治疗药物 | |
CN103864957A (zh) | 基于环糊精载体的青蒿素前药及其制备方法 | |
CN104876974A (zh) | 二茂铁四氮唑离子化合物及其制备方法 | |
US8283473B2 (en) | Platinum complex compound and utilization of the same | |
CN106608892B (zh) | 含氟水溶性铂配合物及制备方法及用途 | |
CN101220037B (zh) | 10-位取代高喜树碱类化合物及其用途 | |
CN101084221B (zh) | 喜树碱的立体有择法和晶型 | |
Shankar et al. | Bottom up synthesis for homo-and heterometallic 2, 3-pyridinedicarboxylate coordination compounds | |
Roy et al. | Combined palladium/eosin Y-catalysed direct synthesis of anticancer biarylquinolinooxazocino-quinoxaline-1-ones under visible light in one-pot sequence: a revisited proof of concept | |
Yamanari et al. | Diastereomeric separations and crystal structures of rhodium (III) and iridium (III) complexes containing adenosine and related nucleosides | |
JP2012533612A (ja) | セレノキノン由来の活性有機金属錯体、該錯体の製造方法、および、該錯体の用途 | |
Zolfigol1Ε et al. | Amir Mohammad Naseri1, Mahmoud Zarei1Ε, Saber Alizadeh1Ε, Saeed Babaee1 | |
CN106608897B (zh) | 含氯水溶性铂配合物及制备方法及用途 | |
Siemeling | Organometallic compounds as complexing agents: a rare example of a crystalline alkali metal podate | |
CN101117320B (zh) | 制备o-去甲文拉法辛的方法 | |
WO2014198140A1 (zh) | 一种铂(ⅱ)配合物、其制备方法、药物组合物及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NIIKI PHARMACEUTICAL ACQUIRING CORPORATION 2 Free format text: FORMER OWNER: FAUSTUS FORSCHUNG TRANSLATIONA Effective date: 20131126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131126 Address after: American Florida Patentee after: NIIKI PHARMA INC. Address before: American New Jersey Patentee before: Niiki Pharma Inc. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131120 Termination date: 20160610 |